Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β Induced Synaptic Dysfunction and Loss.

Salazar SV, Cox TO, Lee S, Brody AH, Chyung AS, Haas LT, Strittmatter SM.

J Neurosci. 2018 Dec 5. pii: 1873-18. doi: 10.1523/JNEUROSCI.1873-18.2018. [Epub ahead of print]

PMID:
30518596
2.

Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.

Brody AH, Strittmatter SM.

Adv Pharmacol. 2018;82:293-323. doi: 10.1016/bs.apha.2017.09.007. Epub 2017 Oct 25.

PMID:
29413525
3.

Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition.

Musante V, Li L, Kanyo J, Lam TT, Colangelo CM, Cheng SK, Brody AH, Greengard P, Le Novère N, Nairn AC.

Elife. 2017 Jun 14;6. pii: e24998. doi: 10.7554/eLife.24998.

4.

ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase).

Andrade EC, Musante V, Horiuchi A, Matsuzaki H, Brody AH, Wu T, Greengard P, Taylor JR, Nairn AC.

J Neurosci. 2017 Mar 8;37(10):2709-2722. doi: 10.1523/JNEUROSCI.4559-15.2017. Epub 2017 Feb 6.

Supplemental Content

Loading ...
Support Center